CREON contains pancreatin in the form of minimicrospheres that provide uniform mixing of enzymes with food for effective nutrient digestion. The medication helps compensate for pancreatic enzyme deficiency and supports healthy digestion.
Recommended for:
The effectiveness of pancreatin has been confirmed in numerous gastroenterology studies. The minimicrosphere technology used in CREON allows more physiological enzyme distribution in the intestine compared to conventional tablet formulations. Clinical studies demonstrated improved fat digestion, reduced steatorrhea, and relief of digestive discomfort symptoms in patients with pancreatic insufficiency.
The medication is indicated for enzyme replacement therapy in pancreatic insufficiency. It is used in chronic pancreatitis, cystic fibrosis, digestive disorders, and after gastrointestinal surgery. Pancreatin helps break down proteins, fats, and carbohydrates, improving nutrient absorption and digestion.
The medication should be taken orally during or immediately after meals. Capsules should be swallowed whole with sufficient water. If necessary, the capsule may be carefully opened and the minimicrospheres mixed with soft food without chewing. Dosage is determined individually depending on the severity of enzyme deficiency and dietary habits.
Contraindications:
Side effects:
